Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | epsilon tubulin, putative | Curated by TDR Targets | References |
Leishmania major | gamma-tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | delta tubulin, putative | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | zeta tubulin, putative | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | alpha tubulin | Curated by TDR Targets | References |
Leishmania major | beta tubulin | Curated by TDR Targets | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Trypanosoma brucei | epsilon tubulin | epsilon tubulin, putative | 470 aa | 488 aa | 68.0 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin epsilon chain, putative | gamma-tubulin | 447 aa | 479 aa | 28.2 % |
Plasmodium falciparum | tubulin gamma chain | beta tubulin | 443 aa | 438 aa | 33.6 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Plasmodium falciparum | tubulin gamma chain | alpha tubulin | 451 aa | 457 aa | 30.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | tubulin alpha chain | 0.0471 | 0.1363 | 0.1361 |
Giardia lamblia | Alpha-tubulin | 0.0471 | 0.1363 | 0.7454 |
Echinococcus granulosus | expressed conserved protein | 0.01 | 0.0258 | 0.1106 |
Plasmodium falciparum | glutathione reductase | 0.0037 | 0.0069 | 0.0342 |
Brugia malayi | Nuclear hormone receptor family member nhr-1 | 0.003 | 0.005 | 0.0264 |
Echinococcus granulosus | tubulin gamma 1 chain | 0.0384 | 0.1104 | 0.4763 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.003 | 0.005 | 0.0207 |
Plasmodium vivax | SET domain protein, putative | 0.0032 | 0.0053 | 0.0259 |
Schistosoma mansoni | tubulin subunit gamma | 0.0384 | 0.1104 | 0.4763 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0035 | 0.0064 | 0.0318 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.008 | 0.0197 | 0.0195 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0625 | 0.1821 | 0.7862 |
Schistosoma mansoni | patched 1 | 0.0046 | 0.0096 | 0.0405 |
Echinococcus multilocularis | tubulin subunit beta | 0.0625 | 0.1821 | 0.1819 |
Schistosoma mansoni | tubulin subunit alpha | 0.0471 | 0.1363 | 0.588 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0471 | 0.1363 | 0.7473 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0007 | 0.0028 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0037 | 0.007 | 0.0293 |
Plasmodium falciparum | tubulin delta chain, putative | 0.0161 | 0.044 | 0.2387 |
Brugia malayi | Muscleblind-like protein | 0.0144 | 0.039 | 0.2129 |
Mycobacterium tuberculosis | Probable peptide synthetase Nrp (peptide synthase) | 0.0016 | 0.0007 | 0.0149 |
Brugia malayi | hypothetical protein | 0.0038 | 0.0073 | 0.0387 |
Trypanosoma brucei | beta tubulin | 0.0625 | 0.1821 | 1 |
Giardia lamblia | Gamma tubulin | 0.0384 | 0.1104 | 0.6018 |
Echinococcus granulosus | tubulin alpha 1C chain | 0.0471 | 0.1363 | 0.588 |
Schistosoma mansoni | hypothetical protein | 0.0044 | 0.0091 | 0.0383 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0791 | 0.2316 | 1 |
Schistosoma mansoni | alpha tubulin | 0.0471 | 0.1363 | 0.588 |
Schistosoma mansoni | alpha glucosidase | 0.0035 | 0.0064 | 0.0268 |
Trypanosoma cruzi | GTP-binding nuclear protein rtb2, putative | 0.0021 | 0.002 | 0.0077 |
Trichomonas vaginalis | ran, putative | 0.0021 | 0.002 | 0.0077 |
Leishmania major | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Entamoeba histolytica | tubulin family protein | 0.0625 | 0.1821 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD35 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0038 | 0.0073 | 0.1659 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0027 | 0.0111 |
Echinococcus granulosus | cpg binding protein | 0.0033 | 0.0057 | 0.0239 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0054 | 0.012 | 0.1523 |
Plasmodium vivax | tubulin epsilon chain, putative | 0.0384 | 0.1103 | 0.604 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0053 | 0.0222 |
Trypanosoma brucei | BRCA1 C Terminus (BRCT) domain containing protein, putative | 0.0041 | 0.008 | 0.0406 |
Echinococcus granulosus | nibrin | 0.0041 | 0.008 | 0.0337 |
Loa Loa (eye worm) | tubulin gamma chain | 0.0384 | 0.1104 | 0.6058 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.003 | 0.005 | 0.0207 |
Schistosoma mansoni | alpha-glucosidase | 0.0136 | 0.0366 | 0.1572 |
Echinococcus granulosus | tubulin alpha chain | 0.0471 | 0.1363 | 0.588 |
Brugia malayi | tubulin alpha chain - mouse | 0.0471 | 0.1363 | 0.7479 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0037 | 0.0069 | 0.1561 |
Echinococcus multilocularis | snurportin 1 | 0.0297 | 0.0846 | 0.0844 |
Echinococcus granulosus | tubulin alpha 1C chain | 0.0471 | 0.1363 | 0.588 |
Brugia malayi | Voltage-gated potassium channel, KCNQ (Kv7-like) alpha-subunit. C. elegans kqt-1 ortholog | 0.0299 | 0.085 | 0.466 |
Leishmania major | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Brugia malayi | nuclear receptor RXR | 0.0016 | 0.0007 | 0.0028 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.006 | 0.0138 | 0.0722 |
Trypanosoma cruzi | GTP-binding nuclear protein rtb2, putative | 0.0021 | 0.002 | 0.0077 |
Brugia malayi | ATP dependent DNA ligase C terminal region family protein | 0.0041 | 0.008 | 0.0429 |
Echinococcus multilocularis | GTP binding nuclear protein Ran | 0.0021 | 0.002 | 0.0018 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0471 | 0.1363 | 0.7473 |
Echinococcus granulosus | beta tubulin | 0.0625 | 0.1821 | 0.7862 |
Brugia malayi | topoisomerase | 0.0041 | 0.008 | 0.0429 |
Plasmodium falciparum | tubulin gamma chain | 0.0384 | 0.1104 | 0.6048 |
Echinococcus multilocularis | nibrin | 0.0041 | 0.008 | 0.0078 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.0351 | 0.1007 | 0.5512 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0161 | 0.044 | 0.2387 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0625 | 0.1821 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0297 | 0.0846 | 0.3646 |
Brugia malayi | AMP-binding enzyme family protein | 0.0016 | 0.0007 | 0.0024 |
Entamoeba histolytica | tubulin gamma chain | 0.0384 | 0.1104 | 0.6048 |
Giardia lamblia | Beta tubulin | 0.0625 | 0.1821 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.008 | 0.0197 | 0.0841 |
Brugia malayi | CHE-14 protein | 0.0046 | 0.0096 | 0.0515 |
Mycobacterium ulcerans | cell division protein FtsZ | 0.0161 | 0.044 | 0.581 |
Trypanosoma brucei | epsilon tubulin | 0.0351 | 0.1007 | 0.5512 |
Echinococcus multilocularis | tubulin alpha 1C chain | 0.0471 | 0.1363 | 0.1361 |
Echinococcus granulosus | FTZ F1 alpha | 0.003 | 0.005 | 0.0207 |
Brugia malayi | Tubulin alpha chain | 0.0471 | 0.1363 | 0.7479 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0471 | 0.1363 | 0.7473 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0035 | 0.0064 | 0.0341 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0625 | 0.1821 | 0.1819 |
Brugia malayi | Nuclear hormone receptor family member nhr-49 | 0.003 | 0.005 | 0.0264 |
Trichomonas vaginalis | glutaminase, putative | 0.0266 | 0.0752 | 0.4108 |
Echinococcus multilocularis | tubulin epsilon chain | 0.0384 | 0.1103 | 0.1101 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0084 | 0.0209 | 0.4745 |
Echinococcus granulosus | potassium channel KvQLT family member kqt 1 | 0.0299 | 0.085 | 0.3664 |
Onchocerca volvulus | 0.0016 | 0.0007 | 0.0063 | |
Brugia malayi | hypothetical protein | 0.0114 | 0.0298 | 0.1625 |
Echinococcus multilocularis | tubulin alpha chain | 0.0471 | 0.1363 | 0.1361 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.003 | 0.005 | 0.0207 |
Brugia malayi | Tubulin alpha chain | 0.0161 | 0.044 | 0.2405 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.003 | 0.005 | 0.0264 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.003 | 0.005 | 0.0207 |
Trypanosoma cruzi | alpha tubulin, putative | 0.0471 | 0.1363 | 0.7473 |
Schistosoma mansoni | hypothetical protein | 0.008 | 0.0197 | 0.0841 |
Loa Loa (eye worm) | voltage-gated potassium channel | 0.0294 | 0.0835 | 0.4578 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0035 | 0.0064 | 0.0318 |
Echinococcus granulosus | FTZ F1 nuclear receptor protein | 0.003 | 0.005 | 0.0207 |
Echinococcus multilocularis | tubulin alpha chain | 0.0471 | 0.1363 | 0.1361 |
Brugia malayi | Pax transcription activation domain interacting protein | 0.0041 | 0.008 | 0.0429 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0054 | 0.012 | 0.0626 |
Brugia malayi | AMP-binding enzyme family protein | 0.0016 | 0.0007 | 0.0024 |
Loa Loa (eye worm) | hypothetical protein | 0.0281 | 0.0796 | 0.4361 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.003 | 0.005 | 0.0264 |
Schistosoma mansoni | hypothetical protein | 0.0044 | 0.0091 | 0.0383 |
Echinococcus granulosus | Tubulin alpha 1 chain | 0.0471 | 0.1363 | 0.588 |
Trypanosoma brucei | importin beta-1 subunit, putative | 0.0028 | 0.0042 | 0.0197 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.012 | 0.0648 |
Echinococcus multilocularis | mitochondrial import inner membrane translocase subunit TIM23, putative | 0.0042 | 0.0085 | 0.0083 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0007 | 0.0028 |
Echinococcus multilocularis | expressed conserved protein | 0.01 | 0.0258 | 0.0256 |
Brugia malayi | RNA binding protein | 0.0185 | 0.0511 | 0.2797 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0471 | 0.1363 | 0.7473 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0084 | 0.0209 | 0.4745 |
Toxoplasma gondii | HEAT repeat-containing protein | 0.0028 | 0.0042 | 0.0197 |
Schistosoma mansoni | tar DNA-binding protein | 0.0185 | 0.0511 | 0.2199 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0084 | 0.0209 | 0.4745 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0161 | 0.044 | 0.2387 |
Brugia malayi | follicle stimulating hormone receptor | 0.0226 | 0.0633 | 0.3469 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.003 | 0.0048 | 0.0198 |
Echinococcus multilocularis | beta tubulin | 0.0625 | 0.1821 | 0.1819 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0144 | 0.039 | 0.0387 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0093 | 0.0236 | 0.5378 |
Brugia malayi | nuclear receptor NHR-88 | 0.003 | 0.005 | 0.0264 |
Toxoplasma gondii | ATPase, AAA family protein | 0.0041 | 0.008 | 0.0406 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.003 | 0.005 | 0.0264 |
Brugia malayi | Nuclear hormone receptor family member nhr-31 | 0.003 | 0.005 | 0.0264 |
Brugia malayi | tubulin alpha-2 chain | 0.0471 | 0.1363 | 0.7479 |
Echinococcus granulosus | tumor protein p63 | 0.0387 | 0.1113 | 0.4802 |
Loa Loa (eye worm) | RNA binding protein | 0.0185 | 0.0511 | 0.2797 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.003 | 0.005 | 0.0264 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.005 | 0.0264 |
Schistosoma mansoni | tar DNA-binding protein | 0.0185 | 0.0511 | 0.2199 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.019 | 0.0527 | 0.2866 |
Echinococcus multilocularis | hypothetical protein | 0.0471 | 0.1363 | 0.1361 |
Echinococcus multilocularis | tubulin gamma 1 chain | 0.0384 | 0.1104 | 0.1102 |
Brugia malayi | Nuclear hormone receptor family member nhr-3 | 0.003 | 0.005 | 0.0264 |
Brugia malayi | Mitochondrial import inner membrane translocase subunit Tim17 family protein | 0.0042 | 0.0085 | 0.0454 |
Brugia malayi | ecdysteroid receptor | 0.003 | 0.005 | 0.0264 |
Schistosoma mansoni | survival motor neuron protein | 0.0047 | 0.0099 | 0.0417 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0054 | 0.012 | 0.2732 |
Echinococcus multilocularis | Tubulin alpha 1 chain | 0.0471 | 0.1363 | 0.1361 |
Loa Loa (eye worm) | hypothetical protein | 0.0134 | 0.036 | 0.1967 |
Schistosoma mansoni | voltage-gated potassium channel KCNQ | 0.0299 | 0.085 | 0.3664 |
Trypanosoma brucei | tubulin delta chain | 0.0363 | 0.104 | 0.5697 |
Trypanosoma cruzi | importin beta-1 subunit, putative | 0.0023 | 0.0027 | 0.0111 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0185 | 0.0511 | 0.2797 |
Trypanosoma cruzi | beta tubulin, putative | 0.0625 | 0.1821 | 1 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0625 | 0.1821 | 0.7862 |
Plasmodium falciparum | mitochondrial import inner membrane translocase subunit TIM10, putative | 0.005 | 0.0107 | 0.0554 |
Plasmodium falciparum | tubulin beta chain | 0.0625 | 0.1821 | 1 |
Plasmodium falciparum | alpha tubulin 2 | 0.0471 | 0.1363 | 0.7473 |
Echinococcus multilocularis | FTZ F1 alpha | 0.003 | 0.005 | 0.0048 |
Echinococcus granulosus | hepatocyte nuclear factor 4 alpha | 0.003 | 0.005 | 0.0207 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.003 | 0.005 | 0.0264 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.0138 | 0.1759 |
Brugia malayi | hypothetical protein | 0.0041 | 0.008 | 0.0429 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.005 | 0.0264 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.012 | 0.0648 |
Loa Loa (eye worm) | tubulin alpha-3 chain | 0.0281 | 0.0796 | 0.4361 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0471 | 0.1363 | 0.7473 |
Schistosoma mansoni | glutaminase | 0.0266 | 0.0752 | 0.3241 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0054 | 0.012 | 0.0626 |
Echinococcus multilocularis | tubulin alpha 3 chain | 0.0471 | 0.1363 | 0.1361 |
Schistosoma mansoni | mitochondrial import inner membrane translocase subunit tim10 | 0.005 | 0.0107 | 0.0453 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0032 | 0.0053 | 0.0222 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0016 | 0.0007 | 0.0024 |
Plasmodium vivax | tubulin gamma chain, putative | 0.0384 | 0.1104 | 0.6048 |
Schistosoma mansoni | tubulin subunit beta | 0.0625 | 0.1821 | 0.7862 |
Trichomonas vaginalis | sucrase-isomaltase, putative | 0.0035 | 0.0064 | 0.0318 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0064 | 0.0318 |
Echinococcus granulosus | tubulin subunit beta | 0.0625 | 0.1821 | 0.7862 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0032 | 0.0053 | 0.0222 |
Mycobacterium ulcerans | glutaminase | 0.0266 | 0.0752 | 1 |
Echinococcus multilocularis | tubulin alpha chain | 0.0471 | 0.1363 | 0.1361 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.008 | 0.0197 | 0.1069 |
Plasmodium vivax | tubulin alpha chain, putative | 0.0471 | 0.1363 | 0.7473 |
Brugia malayi | oxidoreductase, short chain dehydrogenase/reductase family protein | 0.0016 | 0.0007 | 0.0024 |
Loa Loa (eye worm) | hypothetical protein | 0.0471 | 0.1363 | 0.7479 |
Trypanosoma brucei | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Brugia malayi | GTP-binding nuclear protein RAN/TC4 | 0.0021 | 0.002 | 0.0101 |
Echinococcus multilocularis | tubulin alpha 3 chain | 0.0471 | 0.1363 | 0.1361 |
Schistosoma mansoni | tar DNA-binding protein | 0.0185 | 0.0511 | 0.2199 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0054 | 0.012 | 0.1523 |
Plasmodium vivax | delta tubulin, putative | 0.0161 | 0.044 | 0.2387 |
Schistosoma mansoni | thyroid hormone receptor | 0.0158 | 0.0431 | 0.1852 |
Leishmania major | epsilon tubulin, putative | 0.0384 | 0.1103 | 0.604 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0047 | 0.0099 | 0.0531 |
Echinococcus granulosus | Tubulin alpha 1 chain | 0.0471 | 0.1363 | 0.588 |
Plasmodium falciparum | replication factor C subunit 1, putative | 0.0041 | 0.008 | 0.0406 |
Brugia malayi | Nuclear hormone receptor family member nhr-41 | 0.003 | 0.005 | 0.0264 |
Loa Loa (eye worm) | nucleolar RNA-associated protein alpha | 0.0297 | 0.0846 | 0.4637 |
Onchocerca volvulus | 0.0246 | 0.0692 | 1 | |
Leishmania major | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Leishmania major | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Toxoplasma gondii | alpha-tubulin I, putative | 0.0471 | 0.1363 | 0.7473 |
Trypanosoma brucei | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Leishmania major | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD7 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0038 | 0.0073 | 0.1659 |
Trypanosoma brucei | zeta tubulin, putative | 0.0498 | 0.1444 | 0.792 |
Echinococcus multilocularis | FTZ F1 nuclear receptor protein | 0.003 | 0.005 | 0.0048 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0089 | 0.0224 | 0.0222 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.019 | 0.0527 | 0.2866 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0226 | 0.0633 | 0.3469 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.003 | 0.005 | 0.0264 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Brugia malayi | Nuclear hormone receptor family member nhr-40 | 0.003 | 0.005 | 0.0264 |
Plasmodium falciparum | mitochondrial import inner membrane translocase subunit TIM23, putative | 0.0042 | 0.0085 | 0.0431 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.008 | 0.0429 |
Trichomonas vaginalis | tubulin alpha-1 chain, putative | 0.019 | 0.0527 | 0.2866 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0084 | 0.0209 | 0.4745 |
Brugia malayi | Tubulin alpha-2 chain | 0.0471 | 0.1363 | 0.7479 |
Trichomonas vaginalis | tubulin beta-1 chain, putative | 0.0161 | 0.044 | 0.2387 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0185 | 0.0511 | 0.2797 |
Brugia malayi | glutathione reductase | 0.0037 | 0.0069 | 0.0365 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0471 | 0.1363 | 0.7473 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0035 | 0.0064 | 0.0318 |
Echinococcus multilocularis | neutral alpha glucosidase AB | 0.0035 | 0.0064 | 0.0062 |
Brugia malayi | Nuclear hormone receptor family member nhr-14 | 0.003 | 0.005 | 0.0264 |
Echinococcus granulosus | dnaJ subfamily B | 0.0443 | 0.128 | 0.5523 |
Schistosoma mansoni | alpha-glucosidase | 0.0136 | 0.0366 | 0.1572 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.003 | 0.005 | 0.0264 |
Echinococcus multilocularis | cpg binding protein | 0.0033 | 0.0057 | 0.0055 |
Trypanosoma cruzi | epsilon tubulin, putative | 0.0384 | 0.1103 | 0.604 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0035 | 0.0064 | 0.0341 |
Echinococcus granulosus | tubulin epsilon chain | 0.0384 | 0.1103 | 0.4756 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0791 | 0.2316 | 1 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0625 | 0.1821 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.031 | 0.0882 | 0.4839 |
Mycobacterium tuberculosis | Peptide synthetase MbtF (peptide synthase) | 0.0016 | 0.0007 | 0.0149 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0054 | 0.012 | 0.1523 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.0016 | 0.0007 | 0.0022 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0037 | 0.0069 | 0.0342 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.008 | 0.0197 | 0.1069 |
Loa Loa (eye worm) | alpha-tubulin | 0.0471 | 0.1363 | 0.7479 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.006 | 0.0138 | 0.0727 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.003 | 0.005 | 0.0264 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0524 | 0.1522 | 0.6568 |
Echinococcus multilocularis | tumor protein p63 | 0.0387 | 0.1113 | 0.1111 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.0161 | 0.044 | 0.2387 |
Trypanosoma brucei | beta tubulin | 0.0625 | 0.1821 | 1 |
Trypanosoma brucei | GTP-binding nuclear protein rtb2, putative | 0.0021 | 0.002 | 0.0077 |
Mycobacterium ulcerans | hypothetical protein | 0.0054 | 0.012 | 0.1523 |
Echinococcus multilocularis | peroxisome assembly protein 26 | 0.0471 | 0.1363 | 0.1361 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0158 | 0.0431 | 0.0429 |
Schistosoma mansoni | nuclear hormone receptor | 0.003 | 0.005 | 0.0207 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0035 | 0.0064 | 0.0318 |
Brugia malayi | Tubulin beta-1 chain | 0.0625 | 0.1821 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0134 | 0.036 | 0.1967 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0054 | 0.012 | 0.1523 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0041 | 0.008 | 0.0406 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0007 | 0.0024 |
Schistosoma mansoni | alpha tubulin | 0.0471 | 0.1363 | 0.588 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0054 | 0.012 | 0.1523 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0079 | 0.0425 |
Treponema pallidum | cell division protein FtsZ | 0.0161 | 0.044 | 1 |
Echinococcus multilocularis | muscleblind protein | 0.0144 | 0.039 | 0.0387 |
Echinococcus granulosus | neutral alpha glucosidase AB | 0.0035 | 0.0064 | 0.0268 |
Schistosoma mansoni | ran | 0.0021 | 0.002 | 0.0079 |
Schistosoma mansoni | thyroid hormone receptor | 0.0158 | 0.0431 | 0.1852 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0216 | 0.0604 | 0.3306 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Schistosoma mansoni | tubulin subunit beta | 0.0625 | 0.1821 | 0.7862 |
Plasmodium falciparum | tubulin epsilon chain, putative | 0.0384 | 0.1103 | 0.604 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0107 | 0.0277 | 0.0275 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.0384 | 0.1103 | 0.604 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0064 | 0.0318 |
Brugia malayi | Pre-SET motif family protein | 0.0032 | 0.0053 | 0.0282 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0258 | 0.0728 | 0.3991 |
Trypanosoma cruzi | tubulin gamma chain | 0.0384 | 0.1104 | 0.6048 |
Entamoeba histolytica | hypothetical protein | 0.0114 | 0.0298 | 0.1605 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0625 | 0.1821 | 0.1819 |
Loa Loa (eye worm) | glutathione reductase | 0.0037 | 0.0069 | 0.0365 |
Brugia malayi | Tubulin alpha-2 chain | 0.0471 | 0.1363 | 0.7479 |
Echinococcus multilocularis | GPCR, family 2 | 0.008 | 0.0197 | 0.0195 |
Entamoeba histolytica | Ran family GTPase | 0.0021 | 0.002 | 0.0077 |
Trypanosoma brucei | beta tubulin | 0.0625 | 0.1821 | 1 |
Trypanosoma brucei | glucosidase, putative | 0.0035 | 0.0064 | 0.0318 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.0625 | 0.1821 | 1 |
Echinococcus granulosus | importin subunit beta 1 | 0.0028 | 0.0042 | 0.0174 |
Brugia malayi | Mitochondrial import inner membrane translocase subunit TIM10 | 0.005 | 0.0107 | 0.0576 |
Brugia malayi | Tubulin gamma chain | 0.0384 | 0.1104 | 0.6058 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.003 | 0.005 | 0.0207 |
Leishmania major | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Brugia malayi | Tubulin beta chain | 0.0161 | 0.044 | 0.2405 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.008 | 0.0429 |
Echinococcus granulosus | tubulin alpha 3 chain | 0.0471 | 0.1363 | 0.588 |
Brugia malayi | CXXC zinc finger family protein | 0.0031 | 0.0052 | 0.0274 |
Schistosoma mansoni | hypothetical protein | 0.0524 | 0.1522 | 0.6568 |
Loa Loa (eye worm) | hypothetical protein | 0.0229 | 0.0643 | 0.3521 |
Toxoplasma gondii | GTP-binding nuclear protein ran/tc4 | 0.0021 | 0.002 | 0.0077 |
Loa Loa (eye worm) | TAR-binding protein | 0.0185 | 0.0511 | 0.2797 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0625 | 0.1821 | 0.1819 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0108 | 0.0282 | 0.121 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.003 | 0.005 | 0.0695 |
Echinococcus granulosus | potassium voltage gated channel subfamily KQT | 0.0134 | 0.036 | 0.1547 |
Echinococcus multilocularis | protein dispatched 1 | 0.0052 | 0.0115 | 0.0113 |
Onchocerca volvulus | Bile acid receptor homolog | 0.003 | 0.005 | 0.0695 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.0128 | 0.0693 |
Schistosoma mansoni | hypothetical protein | 0.0042 | 0.0085 | 0.0357 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.006 | 0.0138 | 0.0722 |
Plasmodium vivax | GTP-binding nuclear protein RAN/TC4, putative | 0.0021 | 0.002 | 0.0077 |
Echinococcus granulosus | geminin | 0.0524 | 0.1522 | 0.6568 |
Trichomonas vaginalis | tubulin, putative | 0.019 | 0.0527 | 0.2866 |
Leishmania major | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD5 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0038 | 0.0073 | 0.1659 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0079 | 0.0425 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.003 | 0.005 | 0.0048 |
Loa Loa (eye worm) | tubulin beta-2A chain | 0.0625 | 0.1821 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0041 | 0.008 | 0.0406 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0035 | 0.0064 | 0.0318 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0054 | 0.012 | 0.1523 |
Schistosoma mansoni | hypothetical protein | 0.0128 | 0.034 | 0.146 |
Trichomonas vaginalis | tubulin alpha-1 chain, putative | 0.0281 | 0.0796 | 0.4348 |
Brugia malayi | Niemann-Pick C1 protein precursor | 0.0107 | 0.0277 | 0.1512 |
Brugia malayi | hypothetical protein | 0.0041 | 0.008 | 0.0429 |
Mycobacterium tuberculosis | Possible fatty-acid-CoA ligase FadD1 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0007 | 0.0149 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0007 | 0.0028 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0114 | 0.0298 | 0.1278 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.005 | 0.0264 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.0138 | 0.0586 |
Trichomonas vaginalis | chromosome transmission fidelity factor, putative | 0.0041 | 0.008 | 0.0406 |
Plasmodium falciparum | thioredoxin reductase | 0.0037 | 0.0069 | 0.0342 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0791 | 0.2316 | 0.2314 |
Trypanosoma cruzi | zeta tubulin, putative | 0.0498 | 0.1444 | 0.792 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0625 | 0.1821 | 1 |
Schistosoma mansoni | ecdysone-induced protein 78c (dr-78) | 0.0016 | 0.0007 | 0.0022 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD8 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0007 | 0.0149 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0252 | 0.071 | 0.3889 |
Leishmania major | zeta tubulin, putative | 0.0498 | 0.1444 | 0.792 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0085 | 0.0454 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.0138 | 0.1759 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0161 | 0.044 | 0.2387 |
Leishmania major | importin beta-1 subunit, putative | 0.0023 | 0.0027 | 0.0111 |
Schistosoma mansoni | tubulin subunit delta | 0.0161 | 0.044 | 0.1891 |
Echinococcus multilocularis | tubulin beta 1 chain | 0.0625 | 0.1821 | 0.1819 |
Brugia malayi | nuclear hormone receptor | 0.003 | 0.005 | 0.0264 |
Brugia malayi | Cell division protein ftsZ | 0.0161 | 0.044 | 0.2405 |
Brugia malayi | Importin beta-1 subunit | 0.0028 | 0.0042 | 0.0221 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Schistosoma mansoni | DNA ligase IV | 0.0041 | 0.008 | 0.0337 |
Loa Loa (eye worm) | potassium voltage-gated channel subfamily Q member 5 | 0.0134 | 0.036 | 0.1967 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0037 | 0.0069 | 0.0365 |
Echinococcus granulosus | peroxisome assembly protein 26 | 0.0471 | 0.1363 | 0.588 |
Onchocerca volvulus | 0.0031 | 0.0052 | 0.0723 | |
Echinococcus granulosus | expressed protein | 0.005 | 0.0107 | 0.0453 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0107 | 0.0277 | 0.1189 |
Trichomonas vaginalis | chromosome transmission fidelity factor, putative | 0.0041 | 0.008 | 0.0406 |
Loa Loa (eye worm) | alpha-tubulin isotype 2 | 0.031 | 0.0882 | 0.4839 |
Wolbachia endosymbiont of Brugia malayi | cell division protein FtsZ | 0.0161 | 0.044 | 1 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0152 | 0.0414 | 0.1779 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0007 | 0.0028 |
Toxoplasma gondii | poly(ADP-ribose) polymerase catalytic domain-containing protein | 0.0041 | 0.008 | 0.0406 |
Trypanosoma brucei | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Echinococcus multilocularis | Tubulin alpha 1 chain | 0.0471 | 0.1363 | 0.1361 |
Echinococcus multilocularis | potassium voltage gated channel subfamily KQT | 0.0299 | 0.085 | 0.0848 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0054 | 0.012 | 0.0626 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.003 | 0.005 | 0.0264 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.003 | 0.005 | 0.0695 |
Echinococcus granulosus | replication factor c subunit 1 | 0.0041 | 0.008 | 0.0337 |
Trypanosoma brucei | trypanothione reductase | 0.0037 | 0.0069 | 0.0342 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.008 | 0.0429 |
Brugia malayi | Thioredoxin reductase | 0.0037 | 0.0069 | 0.0365 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0054 | 0.012 | 0.0626 |
Echinococcus multilocularis | tubulin delta chain | 0.0161 | 0.044 | 0.0438 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.003 | 0.005 | 0.0207 |
Echinococcus granulosus | ecdysone induced protein 78C | 0.003 | 0.005 | 0.0207 |
Echinococcus multilocularis | tubulin alpha | 0.0351 | 0.1007 | 0.1005 |
Echinococcus multilocularis | dnaJ subfamily B | 0.0443 | 0.128 | 0.1278 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.003 | 0.005 | 0.0207 |
Trypanosoma cruzi | tubulin delta chain | 0.0363 | 0.104 | 0.5697 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0229 | 0.0643 | 0.2768 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0158 | 0.0432 | 0.043 |
Echinococcus granulosus | tubulin alpha chain | 0.0471 | 0.1363 | 0.588 |
Giardia lamblia | Delta tubulin | 0.0161 | 0.044 | 0.2328 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0035 | 0.0064 | 0.0318 |
Schistosoma mansoni | tubulin subunit alpha | 0.0161 | 0.044 | 0.1891 |
Trichomonas vaginalis | tubulin alpha-1 chain, putative | 0.031 | 0.0882 | 0.4827 |
Onchocerca volvulus | 0.0047 | 0.0099 | 0.1399 | |
Toxoplasma gondii | beta-tubulin, putative | 0.0625 | 0.1821 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0041 | 0.008 | 0.0406 |
Loa Loa (eye worm) | hypothetical protein | 0.0252 | 0.071 | 0.3889 |
Loa Loa (eye worm) | tubulin beta-4 chain | 0.0625 | 0.1821 | 1 |
Trichomonas vaginalis | Importin beta-1 subunit, putative | 0.0023 | 0.0027 | 0.0111 |
Echinococcus granulosus | tubulin beta 1 chain | 0.0625 | 0.1821 | 0.7862 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0067 | 0.0159 | 0.068 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0035 | 0.0064 | 0.0318 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0079 | 0.0425 |
Brugia malayi | DKFZp564C0469 protein | 0.0041 | 0.008 | 0.0429 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0054 | 0.012 | 0.0626 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.004 | 0.0079 | 0.0978 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0252 | 0.071 | 0.3889 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0054 | 0.012 | 0.2622 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0041 | 0.008 | 0.0406 |
Mycobacterium tuberculosis | P-hydroxybenzoyl-AMP ligase FadD22 | 0.0016 | 0.0007 | 0.0149 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0041 | 0.008 | 0.0406 |
Schistosoma mansoni | chromosome transmission fidelity factor | 0.0041 | 0.008 | 0.0337 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.005 | 0.0264 |
Echinococcus multilocularis | replication factor c subunit 1 | 0.0041 | 0.008 | 0.0078 |
Loa Loa (eye worm) | glutaminase 2 | 0.0266 | 0.0752 | 0.4122 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.0384 | 0.1104 | 0.6048 |
Echinococcus granulosus | GTP binding nuclear protein Ran | 0.0021 | 0.002 | 0.0079 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.005 | 0.0264 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.0138 | 0.1759 |
Loa Loa (eye worm) | tubulin alpha-2 chain | 0.0471 | 0.1363 | 0.7479 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0057 | 0.0128 | 0.0545 |
Echinococcus granulosus | muscleblind protein | 0.0144 | 0.039 | 0.1674 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0128 | 0.034 | 0.0338 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0093 | 0.0236 | 0.5378 |
Echinococcus granulosus | tar DNA binding protein | 0.0185 | 0.0511 | 0.2199 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0054 | 0.012 | 0.2732 |
Toxoplasma gondii | mitochondrial import inner membrane translocase subunit TIM10, putative | 0.005 | 0.0107 | 0.0554 |
Plasmodium vivax | importin-beta 2, putative | 0.0028 | 0.0042 | 0.0197 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0035 | 0.0064 | 0.0318 |
Echinococcus granulosus | alpha tubulin | 0.0471 | 0.1363 | 0.588 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0035 | 0.0064 | 0.0318 |
Onchocerca volvulus | 0.0032 | 0.0053 | 0.0743 | |
Entamoeba histolytica | hypothetical protein | 0.0114 | 0.0298 | 0.1605 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0032 | 0.0053 | 0.0051 |
Schistosoma mansoni | tubulin subunit beta | 0.0161 | 0.044 | 0.1891 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.019 | 0.0527 | 0.2866 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.0625 | 0.1821 | 1 |
Brugia malayi | steroid hormone receptor | 0.003 | 0.005 | 0.0264 |
Loa Loa (eye worm) | hypothetical protein | 0.0144 | 0.039 | 0.2129 |
Entamoeba histolytica | tubulin alpha chain, putative | 0.0471 | 0.1363 | 0.7473 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.003 | 0.005 | 0.0207 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0252 | 0.071 | 0.3889 |
Plasmodium vivax | replication factor C subunit 1, putative | 0.0041 | 0.008 | 0.0406 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0089 | 0.0224 | 0.0222 |
Brugia malayi | AMP-binding enzyme family protein | 0.0016 | 0.0007 | 0.0024 |
Schistosoma mansoni | alpha tubulin | 0.0471 | 0.1363 | 0.588 |
Leishmania major | gamma-tubulin | 0.0384 | 0.1104 | 0.6048 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.008 | 0.0197 | 0.0841 |
Trichomonas vaginalis | RNA polymerase II ctd phosphatase, putative | 0.0041 | 0.008 | 0.0406 |
Echinococcus granulosus | beta tubulin | 0.0625 | 0.1821 | 0.7862 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.0197 | 0.1069 |
Trypanosoma brucei | beta tubulin | 0.0625 | 0.1821 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0114 | 0.0298 | 0.0296 |
Onchocerca volvulus | 0.0054 | 0.012 | 0.1709 | |
Loa Loa (eye worm) | tubulin alpha chain | 0.0471 | 0.1363 | 0.7479 |
Brugia malayi | Latrophilin receptor protein 2 | 0.008 | 0.0197 | 0.1069 |
Schistosoma mansoni | topbp1 | 0.0041 | 0.008 | 0.0337 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0158 | 0.0432 | 0.043 |
Schistosoma mansoni | cpg binding protein | 0.0031 | 0.0052 | 0.0216 |
Toxoplasma gondii | tubulin/FtsZ family, GTPase domain-containing protein | 0.0193 | 0.0535 | 0.2915 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.004 | 0.0079 | 0.1808 |
Loa Loa (eye worm) | tubulin beta-1 chain | 0.0625 | 0.1821 | 1 |
Loa Loa (eye worm) | BEN-1 protein | 0.0625 | 0.1821 | 1 |
Loa Loa (eye worm) | glutaminase | 0.0266 | 0.0752 | 0.4122 |
Echinococcus granulosus | Nuclear hormone receptor family member nhr 41 | 0.003 | 0.005 | 0.0207 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.005 | 0.0264 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Onchocerca volvulus | 0.0092 | 0.0233 | 0.3339 | |
Mycobacterium tuberculosis | Fatty-acid-CoA synthetase FadD17 (fatty-acid-CoA synthase) (fatty-acid-CoA ligase) | 0.0016 | 0.0007 | 0.0149 |
Trypanosoma brucei | alpha tubulin, putative | 0.019 | 0.0527 | 0.2866 |
Plasmodium vivax | tubulin alpha chain, putative | 0.0471 | 0.1363 | 0.7473 |
Schistosoma mansoni | tubulin subunit epsilon | 0.0384 | 0.1103 | 0.4756 |
Entamoeba histolytica | tubulin family protein | 0.0625 | 0.1821 | 1 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0258 | 0.0728 | 0.3991 |
Loa Loa (eye worm) | tubulin alpha 2 | 0.031 | 0.0882 | 0.4839 |
Trichomonas vaginalis | replication factor C large subunit, putative | 0.0041 | 0.008 | 0.0406 |
Trichomonas vaginalis | importin beta-1, putative | 0.0023 | 0.0027 | 0.0111 |
Onchocerca volvulus | 0.0016 | 0.0007 | 0.0063 | |
Entamoeba histolytica | Niemann-Pick C1 protein, putative | 0.0107 | 0.0277 | 0.1492 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0053 | 0.0222 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0032 | 0.0053 | 0.0259 |
Trichomonas vaginalis | Importin beta-1 subunit, putative | 0.0023 | 0.0027 | 0.0111 |
Brugia malayi | Pre-SET motif family protein | 0.0216 | 0.0604 | 0.3306 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.003 | 0.005 | 0.0207 |
Giardia lamblia | Alpha-tubulin | 0.0471 | 0.1363 | 0.7454 |
Schistosoma mansoni | tubulin subunit alpha | 0.0471 | 0.1363 | 0.588 |
Leishmania major | delta tubulin, putative | 0.0363 | 0.104 | 0.5697 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.006 | 0.0138 | 0.0136 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0089 | 0.0224 | 0.0959 |
Leishmania major | trypanothione reductase | 0.0037 | 0.0069 | 0.0342 |
Entamoeba histolytica | hypothetical protein | 0.0114 | 0.0298 | 0.1605 |
Echinococcus multilocularis | Nuclear hormone receptor family member nhr 41 | 0.003 | 0.005 | 0.0048 |
Echinococcus multilocularis | Tubulin alpha 1 chain | 0.0471 | 0.1363 | 0.1361 |
Echinococcus multilocularis | tubulin, beta 4A class IVa | 0.0625 | 0.1821 | 0.1819 |
Echinococcus granulosus | tubulin alpha chain | 0.0471 | 0.1363 | 0.588 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0037 | 0.0069 | 0.0342 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0089 | 0.0224 | 0.0959 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0084 | 0.0209 | 0.4665 |
Trypanosoma brucei | beta tubulin | 0.0351 | 0.1007 | 0.5512 |
Echinococcus multilocularis | potassium voltage gated channel subfamily KQT | 0.0134 | 0.036 | 0.0358 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0041 | 0.008 | 0.0406 |
Toxoplasma gondii | tubulin/FtsZ family, GTPase domain-containing protein | 0.0363 | 0.104 | 0.5697 |
Loa Loa (eye worm) | tubulin beta chain | 0.0161 | 0.044 | 0.2405 |
Schistosoma mansoni | hypothetical protein | 0.0172 | 0.0472 | 0.2031 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0032 | 0.0053 | 0.0051 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.008 | 0.0197 | 0.0195 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.003 | 0.005 | 0.0207 |
Brugia malayi | Tubulin beta chain | 0.019 | 0.0527 | 0.2883 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.008 | 0.0429 |
Loa Loa (eye worm) | hypothetical protein | 0.0144 | 0.039 | 0.2129 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.003 | 0.005 | 0.0048 |
Trypanosoma brucei | importin beta-1 subunit, putative | 0.0028 | 0.0042 | 0.0197 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.003 | 0.005 | 0.0264 |
Schistosoma mansoni | hypothetical protein | 0.0044 | 0.0091 | 0.0383 |
Echinococcus multilocularis | tar DNA binding protein | 0.0185 | 0.0511 | 0.0509 |
Echinococcus granulosus | sterol regulatory element binding protein | 0.0046 | 0.0096 | 0.0405 |
Echinococcus multilocularis | acetyl coenzyme A synthetase, cytoplasmic | 0.0016 | 0.0007 | 0.0004 |
Leishmania major | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Mycobacterium tuberculosis | Possible fatty-acid-CoA ligase FadD10 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0007 | 0.0149 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.003 | 0.005 | 0.0264 |
Loa Loa (eye worm) | tubulin beta chain | 0.0625 | 0.1821 | 1 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0625 | 0.1821 | 0.7862 |
Onchocerca volvulus | 0.003 | 0.005 | 0.0695 | |
Plasmodium vivax | glutathione reductase, putative | 0.0037 | 0.0069 | 0.0342 |
Echinococcus multilocularis | ecdysone induced protein 78C | 0.003 | 0.005 | 0.0048 |
Leishmania major | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Trichomonas vaginalis | set domain proteins, putative | 0.0246 | 0.0692 | 0.3778 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0054 | 0.012 | 0.0626 |
Schistosoma mansoni | hypothetical protein | 0.008 | 0.0197 | 0.0841 |
Echinococcus granulosus | tubulin alpha chain | 0.0471 | 0.1363 | 0.588 |
Schistosoma mansoni | cpg binding protein | 0.0033 | 0.0057 | 0.0239 |
Schistosoma mansoni | hypothetical protein | 0.0443 | 0.128 | 0.5523 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0093 | 0.0236 | 0.5378 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.003 | 0.005 | 0.0264 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0054 | 0.012 | 0.0648 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0053 | 0.0222 |
Schistosoma mansoni | importin beta-1 | 0.0028 | 0.0042 | 0.0174 |
Echinococcus multilocularis | geminin | 0.0524 | 0.1522 | 0.152 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0625 | 0.1821 | 0.1819 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0046 | 0.0096 | 0.0492 |
Trypanosoma cruzi | epsilon tubulin, putative | 0.0384 | 0.1103 | 0.604 |
Trichomonas vaginalis | tubulin, putative | 0.019 | 0.0527 | 0.2866 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0041 | 0.008 | 0.0406 |
Onchocerca volvulus | 0.0041 | 0.008 | 0.113 | |
Trypanosoma brucei | epsilon tubulin | 0.0384 | 0.1103 | 0.604 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0053 | 0.0282 |
Loa Loa (eye worm) | beta-tubulin | 0.0625 | 0.1821 | 1 |
Leishmania major | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0079 | 0.0425 |
Onchocerca volvulus | 0.0016 | 0.0007 | 0.0063 | |
Chlamydia trachomatis | DNA ligase | 0.0041 | 0.008 | 1 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.004 | 0.0079 | 0.0402 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0016 | 0.0007 | 0.0149 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0272 | 0.0771 | 0.4227 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.003 | 0.005 | 0.0264 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0471 | 0.1363 | 0.7473 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0041 | 0.008 | 0.0406 |
Brugia malayi | acetyl-Coenzyme A synthetase 2 | 0.0016 | 0.0007 | 0.0024 |
Schistosoma mansoni | tubulin subunit beta | 0.0625 | 0.1821 | 0.7862 |
Echinococcus granulosus | acetyl coenzyme A synthetase cytoplasmic | 0.0016 | 0.0007 | 0.0019 |
Echinococcus granulosus | tubulin alpha | 0.0351 | 0.1007 | 0.4342 |
Schistosoma mansoni | tar DNA-binding protein | 0.0185 | 0.0511 | 0.2199 |
Loa Loa (eye worm) | BEN-1 protein | 0.0625 | 0.1821 | 1 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.0046 | 0.0096 | 0.0515 |
Brugia malayi | alpha-tubulin | 0.0471 | 0.1363 | 0.7479 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0096 | 0.0515 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.003 | 0.005 | 0.0264 |
Toxoplasma gondii | beta tubulin | 0.0625 | 0.1821 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0172 | 0.0472 | 0.2584 |
Plasmodium falciparum | acyl-CoA synthetase | 0.004 | 0.0079 | 0.0402 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.006 | 0.0138 | 0.0586 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.0472 | 0.2584 |
Echinococcus multilocularis | protein patched | 0.0046 | 0.0096 | 0.0094 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.0277 | 0.1512 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0229 | 0.0643 | 0.0641 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.005 | 0.0264 |
Loa Loa (eye worm) | tubulin alpha 2 | 0.0119 | 0.0315 | 0.1721 |
Plasmodium vivax | mitochondrial import inner membrane translocase subunit TIM10, putative | 0.005 | 0.0107 | 0.0554 |
Schistosoma mansoni | hypothetical protein | 0.0114 | 0.0298 | 0.1278 |
Schistosoma mansoni | tar DNA-binding protein | 0.0185 | 0.0511 | 0.2199 |
Echinococcus multilocularis | tubulin subunit TubB | 0.0471 | 0.1363 | 0.1361 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Loa Loa (eye worm) | tubulin alpha chain | 0.0471 | 0.1363 | 0.7479 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.003 | 0.005 | 0.0207 |
Echinococcus granulosus | tubulin delta chain | 0.0161 | 0.044 | 0.1891 |
Loa Loa (eye worm) | alpha-tubulin | 0.0471 | 0.1363 | 0.7479 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0471 | 0.1363 | 0.7473 |
Leishmania major | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Leishmania major | GTP-binding protein, putative | 0.0021 | 0.002 | 0.0077 |
Giardia lamblia | Replication factor C, subunit 1 | 0.0041 | 0.008 | 0.0332 |
Brugia malayi | Mitochondrial import inner membrane translocase subunit Tim17 family protein | 0.0042 | 0.0085 | 0.0454 |
Loa Loa (eye worm) | transport to inner mitochondrial membrane family member | 0.005 | 0.0107 | 0.0576 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0031 | 0.0052 | 0.0274 |
Entamoeba histolytica | tubulin alpha-1 chain | 0.0471 | 0.1363 | 0.7473 |
Trypanosoma cruzi | zeta tubulin, putative | 0.0498 | 0.1444 | 0.792 |
Echinococcus granulosus | tubulin beta 4A class IVa | 0.0625 | 0.1821 | 0.7862 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0089 | 0.0224 | 0.0959 |
Loa Loa (eye worm) | oxidoreductase | 0.0016 | 0.0007 | 0.0024 |
Mycobacterium leprae | cell division protein FtsZ | 0.0161 | 0.044 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0084 | 0.0209 | 0.4745 |
Plasmodium vivax | mitochondrial import inner membrane translocase subunit TIM23, putative | 0.0042 | 0.0085 | 0.0431 |
Echinococcus granulosus | Tubulin alpha 1 chain | 0.0471 | 0.1363 | 0.588 |
Trypanosoma cruzi | FHA domain containing protein, putative | 0.0041 | 0.008 | 0.0406 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0007 | 0.0028 |
Mycobacterium ulcerans | NAD-dependent DNA ligase LigA | 0.0041 | 0.008 | 0.0988 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.003 | 0.005 | 0.0207 |
Brugia malayi | TAR-binding protein | 0.0185 | 0.0511 | 0.2797 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0016 | 0.0007 | 0.0024 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0152 | 0.0414 | 0.0412 |
Onchocerca volvulus | 0.0057 | 0.0128 | 0.1827 | |
Loa Loa (eye worm) | GTP-binding nuclear protein RAN/TC4 | 0.0021 | 0.002 | 0.0101 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0079 | 0.0425 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0089 | 0.0224 | 0.122 |
Mycobacterium tuberculosis | Probable medium chain fatty-acid-CoA ligase FadD14 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0016 | 0.0007 | 0.0149 |
Mycobacterium tuberculosis | Bifunctional enzyme MbtA: salicyl-AMP ligase (SAL-AMP ligase) + salicyl-S-ArCP synthetase | 0.0016 | 0.0007 | 0.0149 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0007 | 0.0024 |
Trichomonas vaginalis | tubulin, putative | 0.0194 | 0.0537 | 0.2922 |
Trypanosoma brucei | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Onchocerca volvulus | 0.0016 | 0.0007 | 0.0063 | |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0035 | 0.0064 | 0.0318 |
Schistosoma mansoni | coup transcription factor | 0.003 | 0.005 | 0.0207 |
Toxoplasma gondii | mitochondrial inner membrane translocase subunit TIM17, putative | 0.0042 | 0.0085 | 0.0431 |
Loa Loa (eye worm) | steroid hormone receptor | 0.003 | 0.005 | 0.0264 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0089 | 0.0224 | 0.0959 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0035 | 0.0064 | 0.0318 |
Brugia malayi | hypothetical protein | 0.0038 | 0.0073 | 0.0387 |
Entamoeba histolytica | hypothetical protein | 0.0114 | 0.0298 | 0.1605 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0089 | 0.0224 | 0.122 |
Plasmodium falciparum | alpha tubulin 1 | 0.0471 | 0.1363 | 0.7473 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0126 | 0.0683 |
Echinococcus granulosus | tubulin alpha chain | 0.0471 | 0.1363 | 0.588 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0128 | 0.034 | 0.146 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.003 | 0.005 | 0.0207 |
Mycobacterium leprae | PROBABLE DNA LIGASE [NAD DEPENDENT] LIGA (POLYDEOXYRIBONUCLEOTIDE SYNTHASE [NAD+]) | 0.0041 | 0.008 | 0.17 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0158 | 0.0432 | 0.2362 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.008 | 0.0429 |
Echinococcus multilocularis | expressed protein | 0.005 | 0.0107 | 0.0105 |
Leishmania major | alpha tubulin | 0.0471 | 0.1363 | 0.7473 |
Brugia malayi | beta-tubulin, identical | 0.0625 | 0.1821 | 1 |
Trypanosoma brucei | tubulin gamma chain | 0.0384 | 0.1104 | 0.6048 |
Schistosoma mansoni | topbp1 | 0.0041 | 0.008 | 0.0337 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0114 | 0.0298 | 0.1278 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD3 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0038 | 0.0073 | 0.1659 |
Trichomonas vaginalis | tubulin alpha-1 chain, putative | 0.0471 | 0.1363 | 0.7473 |
Echinococcus multilocularis | beta tubulin | 0.0625 | 0.1821 | 0.1819 |
Schistosoma mansoni | acetyl-CoA synthetase | 0.0016 | 0.0007 | 0.0019 |
Schistosoma mansoni | tubulin subunit alpha | 0.0471 | 0.1363 | 0.588 |
Brugia malayi | AMP-binding enzyme family protein | 0.0054 | 0.012 | 0.0648 |
Schistosoma mansoni | ran | 0.0021 | 0.002 | 0.0079 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0054 | 0.012 | 0.2622 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0037 | 0.007 | 0.0068 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0054 | 0.012 | 0.1523 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.006 | 0.0138 | 0.3131 |
Giardia lamblia | Epsilon tubulin | 0.0193 | 0.0535 | 0.286 |
Plasmodium falciparum | importin beta, putative | 0.0028 | 0.0042 | 0.0197 |
Schistosoma mansoni | hypothetical protein | 0.008 | 0.0197 | 0.0841 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.012 | 0.0648 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.019 | 0.0527 | 0.2866 |
Onchocerca volvulus | 0.019 | 0.0527 | 0.7599 | |
Schistosoma mansoni | cpg binding protein | 0.0033 | 0.0057 | 0.0239 |
Schistosoma mansoni | hypothetical protein | 0.008 | 0.0197 | 0.0841 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0093 | 0.0236 | 0.5308 |
Echinococcus multilocularis | hepatocyte nuclear factor 4 alpha | 0.003 | 0.005 | 0.0048 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0089 | 0.0224 | 0.0959 |
Brugia malayi | glutaminase DH11.1 | 0.0266 | 0.0752 | 0.4122 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0042 | 0.0221 |
Brugia malayi | AMP-binding enzyme family protein | 0.0016 | 0.0007 | 0.0024 |
Toxoplasma gondii | tubulin, putative | 0.0032 | 0.0055 | 0.0268 |
Toxoplasma gondii | TIM10 family protein, putative | 0.005 | 0.0107 | 0.0554 |
Brugia malayi | AMP-binding enzyme family protein | 0.0054 | 0.012 | 0.0648 |
Trypanosoma cruzi | tubulin delta chain | 0.0363 | 0.104 | 0.5697 |
Echinococcus granulosus | tubulin subunit TubB | 0.0471 | 0.1363 | 0.588 |
Trypanosoma cruzi | BRCA1 C Terminus (BRCT) domain containing protein, putative | 0.0041 | 0.008 | 0.0406 |
Echinococcus granulosus | snurportin 1 | 0.0297 | 0.0846 | 0.3646 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.0138 | 0.0586 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0625 | 0.1821 | 0.7862 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.003 | 0.005 | 0.0264 |
Brugia malayi | RNA, U transporter 1 | 0.0079 | 0.0195 | 0.1063 |
Echinococcus multilocularis | tubulin alpha chain | 0.0471 | 0.1363 | 0.1361 |
Echinococcus multilocularis | tubulin alpha 1C chain | 0.0471 | 0.1363 | 0.1361 |
Echinococcus granulosus | nuclear receptor subfamily 1 group D | 0.0016 | 0.0007 | 0.0022 |
Brugia malayi | Mitochondrial import inner membrane translocase subunit Tim17 family protein | 0.0042 | 0.0085 | 0.0454 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.008 | 0.0197 | 0.0841 |
Echinococcus granulosus | tubulin alpha 3 chain | 0.0471 | 0.1363 | 0.588 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0035 | 0.0064 | 0.0318 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0625 | 0.1821 | 0.7862 |
Echinococcus granulosus | Protein patched homolog 1 | 0.0046 | 0.0096 | 0.0405 |
Plasmodium vivax | tubulin beta chain, putative | 0.0625 | 0.1821 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.005 | 0.0264 |
Toxoplasma gondii | alpha tubulin TUBA1 | 0.0471 | 0.1363 | 0.7473 |
Schistosoma mansoni | tubulin subunit beta | 0.0625 | 0.1821 | 0.7862 |
Schistosoma mansoni | hypothetical protein | 0.0047 | 0.0099 | 0.0417 |
Giardia lamblia | Beta tubulin | 0.0625 | 0.1821 | 1 |
Mycobacterium tuberculosis | Cell division protein FtsZ | 0.0161 | 0.044 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0044 | 0.0091 | 0.0383 |
Schistosoma mansoni | tubulin subunit beta | 0.0625 | 0.1821 | 0.7862 |
Giardia lamblia | Beta tubulin | 0.0625 | 0.1821 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.008 | 0.0429 |
Trypanosoma brucei | epsilon tubulin | 0.0384 | 0.1103 | 0.604 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0158 | 0.0432 | 0.2362 |
Mycobacterium tuberculosis | Peptide synthetase MbtE (peptide synthase) | 0.0016 | 0.0007 | 0.0149 |
Loa Loa (eye worm) | nuclear hormone receptor-like 1 | 0.0258 | 0.0728 | 0.3991 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0007 | 0.0028 |
Toxoplasma gondii | beta-1 tubulin, putative | 0.0625 | 0.1821 | 1 |
Toxoplasma gondii | thioredoxin reductase | 0.0037 | 0.0069 | 0.0342 |
Echinococcus multilocularis | nuclear receptor subfamily 1 group D | 0.0016 | 0.0007 | 0.0005 |
Echinococcus multilocularis | importin subunit beta 1 | 0.0028 | 0.0042 | 0.004 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0625 | 0.1821 | 0.1819 |
Loa Loa (eye worm) | hypothetical protein | 0.0256 | 0.0723 | 0.3963 |
Trypanosoma brucei | zeta tubulin | 0.0498 | 0.1444 | 0.792 |
Entamoeba histolytica | Activator 1 140 kDa subunit, putative | 0.0041 | 0.008 | 0.0406 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Mycobacterium tuberculosis | Probable reductase | 0.0084 | 0.0209 | 0.4745 |
Plasmodium falciparum | GTP-binding nuclear protein RAN/TC4 | 0.0021 | 0.002 | 0.0077 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0158 | 0.0432 | 0.1857 |
Schistosoma mansoni | tubulin subunit beta | 0.0625 | 0.1821 | 0.7862 |
Echinococcus multilocularis | sterol regulatory element binding protein | 0.0046 | 0.0096 | 0.0094 |
Trichomonas vaginalis | tubulin, putative | 0.0625 | 0.1821 | 1 |
Trichomonas vaginalis | RNA polymerase II ctd phosphatase, putative | 0.0041 | 0.008 | 0.0406 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.003 | 0.005 | 0.0048 |
Brugia malayi | hypothetical protein | 0.0229 | 0.0643 | 0.3521 |
Toxoplasma gondii | tubulin/FtsZ family, GTPase domain-containing protein | 0.0351 | 0.1007 | 0.5512 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0007 | 0.0028 |
Loa Loa (eye worm) | tubulin alpha 2 | 0.031 | 0.0882 | 0.4839 |
Leishmania major | beta tubulin | 0.0625 | 0.1821 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Targets |
---|---|---|---|---|---|---|
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 26882 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 26953 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 29919 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 25756 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 29777 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 25113 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 29099 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 28601 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 24472 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 21739 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 28044 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 21309 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 24440 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 20919 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 22594 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 23453 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 21545 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 29554 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 29031 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 23905 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 21179 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 25450 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 22205 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 27459 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 26961 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 22252 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 23996 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 23078 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 20827 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 28024 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 28324 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 29091-21-2. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 7818612 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 26882 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 26953 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29919 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 25756 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29777 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 25113 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29099 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28601 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 24472 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21739 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28044 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21309 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 24440 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 20919 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 22594 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23453 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21545 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29554 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29031 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23905 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21179 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 25450 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 22205 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 27459 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 26961 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 22252 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23996 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23078 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 20827 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28024 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28324 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 26882 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 26953 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29919 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 25756 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29777 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 25113 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29099 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28601 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 24472 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21739 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28044 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21309 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 24440 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 20919 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 22594 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23453 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21545 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29554 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 29031 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23905 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 21179 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 25450 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 22205 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 27459 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 26961 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 22252 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23996 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 23078 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 20827 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28024 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 28324 |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents leads to slow growth of Leishmania sp. in cell assay; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 26882 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 26953 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 29919 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 25756 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 29777 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 25113 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 29099 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 28601 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 24472 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 21739 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 28044 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 21309 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 24440 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 20919 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 22594 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 23453 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 21545 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 29554 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 29031 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 23905 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 21179 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 25450 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 22205 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 27459 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 26961 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 22252 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 23996 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 23078 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 20827 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 28024 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 | |
microtubule polymerization (GO:0046785) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 28324 | |
Annotator: | aaronjr@u.washington.edu | Comment: | Drug: 10228-56-5; Drug: 36317-95-0; Drug: 62409-47-6; Drug: 62745-74-8; Drug: 204634-79-7; Drug: 483279-40-9; Drug: 483279-41-0; Drug: 483279-42-1; Drug: 483279-43-2; Drug: 483279-44-3; Drug: 483279-45-4; Drug: 483279-46-5; Drug: 483279-47-6; Drug: 88-91-5; Drug: 107-10-8; Drug: 1930-72-9; Drug: 97-08-5; Drug: 97-09-6; Drug: 62443-96-3; Drug: 483279-33-0; Drug: 483279-34-1; Drug: 483279-35-2; Drug: 483279-36-3; Drug: 483279-37-4; Drug: 483279-38-5; Drug: 483279-39-6. chemical inhibition with antimicrotubule agents prevents mictotubule formation in vitro with purified tubulin; unclear as to which topoisomerase II gene/enzyme was studied | References: | 12161141 |
4 literature references were collected for this gene.